Peterson A1, Oelke M2, McVary K3, Baygani S4, Henneges C5, Clouth J5, Wong D4, Donatucci C4
1. Department of Surgery and Urology, Duke University, Durham, North Carolina, USA, 2. Department of Urology, Hannover Medical School, Hannover, Germany, 3. Department of Urology, Southern Illinois University, Springfield, Illinois, USA, 4. Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA, 5. Lilly Deutschland GmbH, Bad Homburg, Germany
Benign Prostatic Hyperplasia (BPH), Quality of Life (QoL), Male, Mathematical or statistical modelling